Evidence map›Paper›PMID 29358700›Full record

ArticleCell death & disease2018

BIM and NOXA are mitochondrial effectors of TAF6δ-driven apoptosis.

Aurélie Delannoy, Emmanuelle Wilhelm, Sebastian Eilebrecht, Edith Milena Alvarado-Cuevas, Arndt G Benecke, Brendan Bell

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Identification ofBiology · 2022
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 4 countries.

Aurélie DelannoyRNA Group, Département de microbiologie et d'infectiologie, Faculté de médecine et sciences de la santé, Université de Sherbrooke and Centre de recherche du CHUS, Sherbrooke, QC, Canada.ORCID 0000-0001-7887-5980
Emmanuelle WilhelmRNA Group, Département de microbiologie et d'infectiologie, Faculté de médecine et sciences de la santé, Université de Sherbrooke and Centre de recherche du CHUS, Sherbrooke, QC, Canada.
Sebastian EilebrechtCNRS UMR8246, Université Pierre et Marie Curie, 75005, Paris, France.
Edith Milena Alvarado-CuevasRNA Group, Département de microbiologie et d'infectiologie, Faculté de médecine et sciences de la santé, Université de Sherbrooke and Centre de recherche du CHUS, Sherbrooke, QC, Canada.
Arndt G BeneckeCNRS UMR8246, Université Pierre et Marie Curie, 75005, Paris, France.
Brendan BellRNA Group, Département de microbiologie et d'infectiologie, Faculté de médecine et sciences de la santé, Université de Sherbrooke and Centre de recherche du CHUS, Sherbrooke, QC, Canada. Brendan.Bell@USherbrooke.ca.ORCID 0000-0001-6885-940X
Université de Sherbrooke · CACentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TAF6δ is a pro-apoptotic splice variant of the RNA polymerase II general transcription factor, TAF6, that can dictate life vs. death decisions in animal cells. TAF6δ stands out from classical pro-apoptotic proteins because it is encoded by a gene that is essential at the cellular level, and because it functions as a component of the basal transcription machinery. TAF6δ has been shown to modulate the transcriptome landscape, but it is not known if changes in gene expression trigger apoptosis nor which TAF6δ-regulated genes contribute to cell death. Here we used microarrays to interrogate the genome-wide impact of TAF6δ on transcriptome dynamics at temporal resolution. The results revealed changes in pro-apoptotic BH3-only mitochondrial genes that correlate tightly with the onset of cell death. These results prompted us to test and validate a role for the mitochondrial pathway by showing that TAF6δ expression causes cytochrome c release into the cytoplasm. To further dissect the mechanism by which TAF6δ drives apoptosis, we pinpointed BIM and NOXA as candidate effectors. siRNA experiments showed that both BIM and NOXA contribute to TAF6δ-dependent cell death. Our results identify mitochondrial effectors of TAF6δ-driven apoptosis, thereby providing the first of mechanistic framework underlying the atypical TAF6δ apoptotic pathway's capacity to intersect with the classically defined apoptotic machinery to trigger cell death.

Indexed as

ApoptosisBcl-2-Like Protein 11bcl-X ProteinCell Line, TumorCisplatinCytochromes cGene OntologyHumansMitochondriaProto-Oncogene Proteins c-bcl-2TATA-Binding Protein Associated FactorsTime FactorsTNF-Related Apoptosis-Inducing LigandTranscriptional ActivationTranscriptomeBcl-2-Like Protein 11bcl-X ProteinCisplatinCytochromes cPMAIP1 protein, humanProto-Oncogene Proteins c-bcl-2TAF6 protein, humanTATA-Binding Protein Associated FactorsTNF-Related Apoptosis-Inducing Ligand

Identifiers

PMID29358700
PMCPMC5833734
OpenAlexW2791307733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.